The immunobiology of primary sclerosing cholangitis

被引:58
作者
Aoki, CA
Bowlus, CL
Gershwin, ME
机构
[1] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA
[2] Univ Calif Davis, Div Gastroenterol, Sacramento, CA 95817 USA
关键词
primary sclerosing cholangitis; immunobiology; HLA polymorphisms; bacterial antigens; lymphocyte homing; TNF alpha; Autoantibodies;
D O I
10.1016/j.autrev.2004.09.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An understanding of the immunobiology of primary sclerosing cholangitis (PSC) is essential to improving both diagnosis and treatment. There have been significant gains in the discovery of genetic polymorphisms that generate susceptibility to disease, but only limited data on etiologic events that may initiate the inflammatory response. Colonic inflammation produces memory T cells that have the ability to bind both biliary and colonic endothelial cells. One possible mechanism for the development of PSC is the homing of these memory T cells to the biliary tree. In addition, TNF alpha may contribute to the oxidative damage of the biliary system. Finally, although speculative, mononuclear cell responses against biliary epithelial cells may create a persistent inflammatory response, eventually leading to fibrosis. (C) 2004 Published by Elsevier B.V.
引用
收藏
页码:137 / 143
页数:7
相关论文
共 40 条
  • [1] Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community
    Bambha, K
    Kim, WR
    Talwalkar, J
    Torgerson, H
    Benson, JT
    Therneau, TM
    Loftus, EV
    Yawn, BP
    Dickson, ER
    Melton, LJ
    [J]. GASTROENTEROLOGY, 2003, 125 (05) : 1364 - 1369
  • [2] Cytokines in primary biliary cirrhosis
    Berg, PA
    Klein, R
    Röcken, M
    [J]. SEMINARS IN LIVER DISEASE, 1997, 17 (02) : 115 - 123
  • [3] Björnsson ES, 2000, HEPATO-GASTROENTEROL, V47, P1504
  • [4] Tumour necrosis factor α impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis
    Bo, X
    Broome, U
    Remberger, M
    Sumitran-Holgersson, S
    [J]. GUT, 2001, 49 (01) : 131 - 141
  • [5] Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis
    Broome, U
    Olsson, R
    Loof, L
    Bodemar, G
    Hultcrantz, R
    Danielsson, A
    Prytz, H
    SandbergGertzen, H
    Wallerstedt, S
    Lindberg, G
    [J]. GUT, 1996, 38 (04) : 610 - 615
  • [6] DISTRIBUTION OF HLA-DR, HLA-DP, HLA-DQ ANTIGENS IN LIVER-TISSUE FROM PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    BROOME, U
    GLAUMANN, H
    HULTCRANTZ, R
    FORSUM, U
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1990, 25 (01) : 54 - 58
  • [7] Broome U, 1997, J HEPATOL, V26, P527
  • [8] Accumulation of macrophages in primary sclerosing cholangitis
    Cameron, RG
    Blendis, LM
    Neuman, MG
    [J]. CLINICAL BIOCHEMISTRY, 2001, 34 (03) : 195 - 201
  • [9] Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis
    Cruickshank, SM
    Southgate, J
    Wyatt, JI
    Selby, PJ
    Trejdosiewicz, LK
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (10) : 730 - 734
  • [10] Inhibition of T cell activation by normal human biliary epithelial cells
    Cruickshank, SM
    Southgate, J
    Selby, PJ
    Trejdosiewicz, LK
    [J]. JOURNAL OF HEPATOLOGY, 1999, 31 (06) : 1026 - 1033